Sanofi and MyoKardia announce groundbreaking collaboration to develop targeted therapies for patients with genetic heart disease
19 September 2014 | By Sanofi
Sanofi and MyoKardia, Inc. announced a worldwide collaboration to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies, the most common forms of heart muscle disease...